Globus Medical (GMED) News & Sentiment

AUDUBON, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a top company in musculoskeletal technology, has announced two new products: the COHERE™ ALIF Spacer, which is the first Porous PEEK™ interbody spacer designed for anterior lumbar interbody fusion (ALIF) surgery, and the Modulus™ ALIF Blades, which expand the popular Modulus™ ALIF interbody spacer system.

AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a top company in musculoskeletal technology, has announced its participation in the 2025 Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) taking place in San Diego, California, from March 10-14, 2025.

AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a top company in musculoskeletal technology, has announced that it will take part in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego.

Investors should closely monitor Globus Medical (GMED) stock due to recent changes in the options market.

GMED's performance in the fourth quarter of 2024 shows significant benefits from the merger with NuVasive.

The financial results for Globus Medical (GMED) from the quarter ending in December 2024 provide insight into the company's performance. It may also be helpful to compare some important metrics with Wall Street predictions and figures from the previous year.

AUDUBON, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a top company in musculoskeletal technology, has released its financial results for the fourth quarter and the entire year that ended on December 31, 2024.

Globus Medical (GMED) has the right factors that could lead to a strong earnings report soon. Be ready for the important expectations.

No matter if you invest in value, growth, or momentum stocks, the Zacks Style Scores can help you identify strong stocks more easily. This is one of the best features of the Zacks Premium research service.